Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8044943rdf:typepubmed:Citationlld:pubmed
pubmed-article:8044943lifeskim:mentionsumls-concept:C0035173lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C1623258lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C0016018lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C1442770lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C0040044lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C1515980lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C1521801lld:lifeskim
pubmed-article:8044943lifeskim:mentionsumls-concept:C0205087lld:lifeskim
pubmed-article:8044943pubmed:issue2lld:pubmed
pubmed-article:8044943pubmed:dateCreated1994-8-26lld:pubmed
pubmed-article:8044943pubmed:abstractTextThrombolytic therapy reduces mortality after acute myocardial infarction, even when treatment is initiated relatively late after onset of symptoms. The mechanism underlying this survival benefit is incompletely understood.lld:pubmed
pubmed-article:8044943pubmed:languageenglld:pubmed
pubmed-article:8044943pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8044943pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8044943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8044943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8044943pubmed:statusMEDLINElld:pubmed
pubmed-article:8044943pubmed:monthAuglld:pubmed
pubmed-article:8044943pubmed:issn0009-7322lld:pubmed
pubmed-article:8044943pubmed:authorpubmed-author:ArmstrongP...lld:pubmed
pubmed-article:8044943pubmed:authorpubmed-author:TherouxPPlld:pubmed
pubmed-article:8044943pubmed:authorpubmed-author:MorganC DCDlld:pubmed
pubmed-article:8044943pubmed:authorpubmed-author:NaylorC DCDlld:pubmed
pubmed-article:8044943pubmed:authorpubmed-author:TopolE JEJlld:pubmed
pubmed-article:8044943pubmed:authorpubmed-author:SteinbergJ...lld:pubmed
pubmed-article:8044943pubmed:authorpubmed-author:DorianPPlld:pubmed
pubmed-article:8044943pubmed:authorpubmed-author:HochmanJ SJSlld:pubmed
pubmed-article:8044943pubmed:issnTypePrintlld:pubmed
pubmed-article:8044943pubmed:volume90lld:pubmed
pubmed-article:8044943pubmed:ownerNLMlld:pubmed
pubmed-article:8044943pubmed:authorsCompleteYlld:pubmed
pubmed-article:8044943pubmed:pagination746-52lld:pubmed
pubmed-article:8044943pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:meshHeadingpubmed-meshheading:8044943-...lld:pubmed
pubmed-article:8044943pubmed:year1994lld:pubmed
pubmed-article:8044943pubmed:articleTitleEffects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy.lld:pubmed
pubmed-article:8044943pubmed:affiliationDivision of Cardiology, St Luke's-Roosevelt Hospital Center, New York, NY 10025.lld:pubmed
pubmed-article:8044943pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8044943pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8044943pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8044943pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8044943pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:8044943pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8044943lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8044943lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8044943lld:pubmed